Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26851 | 19652102 | Arch Pediatr Adolesc Med | Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: a 1-year follow-up study. | 2009 | Details |
| A26856 | 19637776 | Acta Gastroenterol Belg | Tumor necrosis factor--alpha gene promoter polymorphisms in Chinese patients with nonalcoholic fatty liver diseases. | 2009 | Details |
| A26857 | 19637730 | Rev Invest Clin | [Pathophysiology of non-alcoholic steatohepatitis. An insulin resistance overview]. | 2009 | Details |
| A26859 | 19637282 | Hepatology | Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. | 2009 | Details |
| A26865 | 19624771 | Hepatol Res | Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease. | 2009 | Details |
| A26873 | 19604596 | J Hepatol | Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. | 2009 | Details |
| A26875 | 19602132 | Liver Int | Liver fat and lipid oxidation in humans. | 2009 | Details |
| A26880 | 19592219 | Nutrition | Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect? | 2009 | Details |
| A26882 | 19588731 | J Physiol Biochem | Serum transaminases concentrations in obese children and adolescents. | 2009 | Details |
| A26887 | 19584882 | Obesity (Silver Spring) | Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. | 2009 | Details |
| A26891 | 19575599 | Annu Rev Nutr | Nonalcoholic fatty liver disease and low-carbohydrate diets. | 2009 | Details |
| A26894 | 19573457 | Zhonghua Er Ke Za Zhi | [Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children]. | 2009 | Details |
| A26897 | 19568858 | Environ Health Prev Med | Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. | 2009 | Details |
| A26910 | 19554810 | J Pediatr Endocrinol Metab | Can the insulin sensitivity index (ISI) in association with insulin-like growth factor binding protein-1 identify insulin resistance early in overweight children? | 2009 | Details |
| A26911 | 19381126 | Ann Hepatol | Is exercise an effective treatment for NASH? Knowns and unknowns. | 2009 | Details |
| A26912 | 19381125 | Ann Hepatol | Treatment regimens for non-alcoholic fatty liver disease. | 2009 | Details |
| A26913 | 19381124 | Ann Hepatol | Association between type two diabetes and non-alcoholic fatty liver disease in youth. | 2009 | Details |
| A26917 | 19381120 | Ann Hepatol | Metabolic syndrome and non-alcoholic fatty liver disease. | 2009 | Details |
| A26918 | 19381119 | Ann Hepatol | New insights into the pathophysiology of nonalcoholic fatty liver disease. | 2009 | Details |
| A26923 | 19542757 | J Endocrinol Invest | Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. | 2009 | Details |
| A26930 | 19525862 | J Clin Gastroenterol | Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD. | 2009 | Details |
| A26931 | 19525859 | J Clin Gastroenterol | Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26932 | 19524579 | Gastroenterology | Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. | 2009 | Details |
| A26934 | 19519467 | Endocr Metab Immune Disord Drug Targets | Dissecting insulin signaling pathways: individualised therapeutic targets for diagnosis and treatment of insulin resistant states. | 2009 | Details |
| A26935 | 19519352 | Curr Drug Targets | Liver fibrosis and therapeutic strategies: the goal for improving metabolism. | 2009 | Details |
| A26938 | 19513842 | Dig Dis Sci | Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C. | 2009 | Details |
| A26939 | 19513120 | PLoS One | Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. | 2009 | Details |
| A26941 | 19502653 | Ann Hepatol | Common SPINK-1 mutations do not predispose to the development of non-alcoholic fatty liver disease. | 2009 | Details |
| A26943 | 19502161 | Hepatobiliary Pancreat Dis Int | Commonly used animal models of non-alcoholic steatohepatitis. | 2009 | Details |
| A26945 | 19491421 | Indian J Med Res | A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease. | 2009 | Details |
| A26946 | 19490416 | Liver Int | Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice. | 2009 | Details |
| A26947 | 19484180 | J Gastroenterol | Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. | 2009 | Details |
| A26948 | 19478676 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems. | 2010 | Details |
| A26949 | 19476560 | J Gastroenterol Hepatol | Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. | 2009 | Details |
| A26950 | 19475694 | Hepatology | Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. | 2009 | Details |
| A26951 | 19474742 | Eur J Gastroenterol Hepatol | Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance. | 2009 | Details |
| A26952 | 19474520 | J Endocrinol Invest | UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity. | 2009 | Details |
| A26955 | 19466213 | Arq Bras Endocrinol Metabol | Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. | 2009 | Details |
| A26957 | 19464851 | Epilepsy Res | Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. | 2009 | Details |
| A26959 | 19464069 | J Hepatol | Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. | 2009 | Details |
| A26960 | 19460054 | Intern Med J | Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. | 2010 | Details |
| A26961 | 19459046 | Dig Dis Sci | Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. | 2009 | Details |
| A26962 | 19452573 | World J Gastroenterol | Signal transduction mechanism of TRB3 in rats with non-alcoholic fatty liver disease. | 2009 | Details |
| A26966 | 19447517 | J Hepatol | Kupffer cells in non-alcoholic fatty liver disease: the emerging view. | 2009 | Details |
| A26968 | 19444865 | Diabetes Metab Res Rev | Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. | 2009 | Details |
| A26969 | 19444112 | Curr Opin Pediatr | The metabolic syndrome and nonalcoholic fatty liver disease in children. | 2009 | Details |
| A26972 | 19440836 | Dig Dis Sci | Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease. | 2009 | Details |
| A26976 | 19424408 | Rev Gastroenterol Peru | [Non alcoholic fatty liver. A frequent entity with an unknown outcome]. | 2009 | Details |
| A26977 | 19423319 | J Nutr Biochem | Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein 1 production in db/db mice. | 2009 | Details |
| A26978 | 19422483 | Liver Int | Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. | 2009 | Details |
| A26982 | 19413701 | Obes Rev | Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. | 2009 | Details |
| A26985 | 19409898 | Gastroenterology | Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. | 2009 | Details |
| A26986 | 19409076 | BMC Med | The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. | 2009 | Details |
| A26987 | 19408737 | Acta Gastroenterol Latinoam | [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?]. | 2009 | Details |
| A26988 | 19403348 | Dig Liver Dis | Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis. | 2009 | Details |
| A26989 | 19396962 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2009 | Details |
| A26991 | 19390517 | Obesity (Silver Spring) | Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. | 2009 | Details |
| A26992 | 19387108 | J Alzheimers Dis | Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. | 2009 | Details |
| A26996 | 19373421 | Can J Gastroenterol | Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis. | 2009 | Details |
| A26998 | 19371271 | Pediatr Int | Ghrelin and leptin modulate immunity and liver function in overweight children. | 2009 | Details |
| A27000 | 19370776 | World J Gastroenterol | Olive oil consumption and non-alcoholic fatty liver disease. | 2009 | Details |
| A27004 | 19366381 | J Am Acad Nurse Pract | Fatty liver in adolescents on the U.S.-Mexico border. | 2009 | Details |
| A27005 | 19363256 | J Alzheimers Dis | Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis. | 2009 | Details |
| A27009 | 19360015 | Obesity (Silver Spring) | Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. | 2009 | Details |
| A27011 | 19359149 | Nutr Metab Cardiovasc Dis | Hepatic lipid metabolism and non-alcoholic fatty liver disease. | 2009 | Details |
| A27013 | 19355912 | Curr Mol Med | Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. | 2009 | Details |
| A27014 | 19353360 | Ann Med | New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). | 2009 | Details |
| A27015 | 19352614 | J Mol Med (Berl) | Molecular mechanisms involved in NAFLD progression. | 2009 | Details |
| A27016 | 19352053 | Endocr J | Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. | 2009 | Details |
| A27019 | 19337636 | J Gastrointestin Liver Dis | Perihepatic adipose tissue thickness: a new non-invasive marker of NAFLD? | 2009 | Details |
| A27023 | 21495339 | Rev Med Chir Soc Med Nat Iasi | [Adipocytokines and nonalcoholic steatohepatitis]. | 2011 | Details |
| A27026 | 19323780 | Liver Int | Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease. | 2009 | Details |
| A27030 | 19317274 | Acta Gastroenterol Belg | Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis. | 2009 | Details |
| A27035 | 19293782 | Am J Gastroenterol | NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. | 2009 | Details |
| A27038 | 19291292 | J Inflamm (Lond) | Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? | 2009 | Details |
| A27044 | 19282820 | Obesity (Silver Spring) | Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55. | 2009 | Details |
| A27047 | 19278843 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. | 2009 | Details |
| A27050 | 19268270 | Clin Gastroenterol Hepatol | Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. | 2009 | Details |
| A27051 | 19267193 | Dig Dis Sci | Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation. | 2009 | Details |
| A27053 | 19261002 | Hepatol Res | Role of hepatic iron in non-alcoholic steatohepatitis. | 2009 | Details |
| A27054 | 19254570 | Cell Metab | The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. | 2009 | Details |
| A27058 | 19246975 | J Endocrinol Invest | Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population. | 2008 | Details |
| A27060 | 19243311 | Clin Sci (Lond) | Metabolic disturbances in non-alcoholic fatty liver disease. | 2009 | Details |
| A27061 | 19242728 | Pediatr Nephrol | Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease. | 2009 | Details |
| A27062 | 19240815 | Hippokratia | Non alcoholic fatty liver disease and metabolic syndrome. | 2009 | Details |
| A27065 | 19230890 | Atherosclerosis | Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. | 2009 | Details |
| A27066 | 19187068 | Liver Int | Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response. | 2009 | Details |
| A27067 | 19226377 | J Gastroenterol Hepatol | Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. | 2008 | Details |
| A27072 | 19223251 | Dig Liver Dis | Non-alcoholic fatty liver disease pathogenesis: the present and the future. | 2009 | Details |
| A27073 | 19222849 | BMC Gastroenterol | Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study. | 2009 | Details |
| A27076 | 19221666 | Ann Acad Med Singap | The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. | 2009 | Details |
| A27077 | 19221529 | Ann Hepatol | Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). | 2009 | Details |
| A27078 | 19221528 | Ann Hepatol | Hepatogenous diabetes. Current views of an ancient problem. | 2009 | Details |
| A27082 | 19215335 | J Gastroenterol Hepatol | An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. | 2009 | Details |
| A27086 | 19202511 | Pediatr Endocrinol Rev | Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. | 2008 | Details |
| A27087 | 19199918 | Curr Med Chem | Obesity: pathophysiology and clinical management. | 2009 | Details |
| A27088 | 19195631 | Diabetes Metab | The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis. | 2008 | Details |
| A27089 | 19195630 | Diabetes Metab | Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis. | 2008 | Details |
| A27091 | 19195628 | Diabetes Metab | How to measure hepatic insulin resistance? | 2008 | Details |
| A27093 | 19195625 | Diabetes Metab | The role of the lipogenic pathway in the development of hepatic steatosis. | 2008 | Details |